CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Class of Warrant or Right, Outstanding
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) had Class of Warrant or Right, Outstanding of 6.30 million shares as of 2013-09-28, per its 10-Q filed 2013-10-30.
Discontinued › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2013-10-30
- 2013-09-28: Class of Warrant or Right, Outstanding 6.30M shares.
- 2013-06-29: Class of Warrant or Right, Outstanding 7.20M shares.
| Period end | Class of Warrant or Right, Outstanding |
|---|---|
| 2013-09-28 | 6.30M shares 10-Q · filed 2013-10-30 |
| 2013-06-29 | 7.20M shares 10-Q · filed 2013-10-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |